[VIEW] agent=Hospital Finance & Operations Director | scenario_id=107 | rounds=20

--- Round 0 ---
[R0.1] Quality & Patient Safety Director (speak, public): To address the Joint Commission's requirements and improve patient safety, we need to discuss the proposed 60-day corrective action plan for inpatient medication reconciliation. Our baseline audit shows admission med rec at 71% and discharge reconciliation at 62% within the required timeframe. The main issues identified are unclear ownership and after-hours admissions. Let's review the plan's scope, system changes, training efforts, and resource requirements.
[R0.2] Pharmacy Informatics Lead (speak, public): Our current medication reconciliation workflow involves 6 steps and takes an average of 18 minutes per patient for pharmacist verification. The proposed EHR change includes a discharge hard-stop for 'Reconcile and Sign', which will require approximately 120 hours of build effort and 2 weeks for testing. We also plan to implement a microlearning module for training, which is 15 minutes long and targets around 850 learners.
[R0.3] Hospital Finance & Operations Director (speak, public): To assess the proposed 60-day corrective action plan, I need to understand its financial and operational implications. Pharmacy Informatics Lead, can you elaborate on the resource requirements for the EHR build and testing effort you've outlined? Additionally, Quality & Patient Safety Director, what is the anticipated reduction in preventable Adverse Drug Events (ADEs) following the implementation of this plan?

--- Round 1 ---
[R1.1] Quality & Patient Safety Director (speak, public): To address the Hospital Finance & Operations Director's question, while we don't have exact figures on the reduction in preventable Adverse Drug Events (ADEs) post-implementation, improving medication reconciliation reliability is expected to decrease medication-related harm events. Pharmacy Informatics Lead, can you confirm if the proposed EHR changes and training will integrate with our current workflow without significant disruptions? Additionally, Hospital Finance & Operations Director, are there any budget constraints or operational capacity limits we should be aware of when assessing the feasibility of this 60-day plan?
[R1.2] Pharmacy Informatics Lead (speak, public): The proposed EHR changes, including the discharge hard-stop for 'Reconcile and Sign', are designed to integrate with our current workflow, but we need to consider the 120 hours of build effort and 2 weeks of testing to ensure a smooth implementation. The microlearning module for training is expected to minimize disruptions as it's only 15 minutes long for the 850 learners. However, I'd like to confirm with Hospital Finance & Operations Director if there are any specific budget constraints or operational capacity limits that could impact our ability to implement this plan within 60 days.
[R1.3] Hospital Finance & Operations Director (speak, public): To assess the operational feasibility of the proposed 60-day corrective action plan, I need to understand the scale of change and training effort required. Pharmacy Informatics Lead, can you provide more details on the potential impact of the EHR changes on our current pharmacist workload and staffing requirements? Additionally, Quality & Patient Safety Director, are there any indicators of patient harm trajectory or operational strain that we should be aware of to gauge execution risk?

--- Round 2 ---
[R2.1] Quality & Patient Safety Director (speak, public): To address the concerns raised, let's summarize the key points: the proposed EHR changes include a discharge hard-stop for 'Reconcile and Sign', requiring 120 hours of build effort and 2 weeks of testing. The training involves a 15-minute microlearning module for approximately 850 learners. We need to assess the impact on pharmacist workload and potential operational strain. Hospital Finance & Operations Director, can you provide insights on budget headroom and potential operational capacity constraints that might affect the 60-day timeline?
[R2.2] Pharmacy Informatics Lead (speak, public): To address the concerns about pharmacist workload, the proposed EHR change with a discharge hard-stop for 'Reconcile and Sign' is expected to streamline the medication reconciliation process, potentially reducing the current average verification time of 18 minutes per patient. However, we need to consider the initial build effort of 120 hours and 2 weeks of testing. Regarding operational capacity, while the microlearning module is designed to be brief, training 850 learners within a short timeframe may still pose a challenge. I'd like to know if there are any contingency plans or additional resources we could leverage to mitigate potential operational strain during the implementation phase.
[R2.3] Hospital Finance & Operations Director (speak, public): To assess the financial viability of the proposed 60-day corrective action plan, I need to understand the total cost implications. Pharmacy Informatics Lead, can you provide a breakdown of the costs associated with the EHR build effort and testing? Additionally, Quality & Patient Safety Director, can you share any insights on the potential reduction in preventable Adverse Drug Events (ADEs) and how it might impact our overall cost savings?

--- Round 3 ---
[R3.1] Quality & Patient Safety Director (speak, public): To move forward, let's summarize the key aspects of the proposed 60-day corrective action plan: the EHR changes include a discharge hard-stop for 'Reconcile and Sign', requiring 120 hours of build effort and 2 weeks of testing. The training involves a 15-minute microlearning module for approximately 850 learners. Pharmacy Informatics Lead has indicated that the EHR change is expected to streamline the medication reconciliation process. Hospital Finance & Operations Director, can you now provide a clearer indication of the budget headroom for this initiative and any potential financial constraints we should consider?
[R3.2] Pharmacy Informatics Lead (speak, public): To further assess the feasibility of the proposed 60-day corrective action plan, I'd like to highlight that while the EHR changes are expected to streamline the medication reconciliation process, the initial build and testing phases will require significant effort. I'd appreciate it if Hospital Finance & Operations Director could provide more clarity on the budget allocation for this initiative and if there are any financial constraints we should be aware of.
[R3.3] Hospital Finance & Operations Director (speak, public): To assess the financial and operational viability of the proposed 60-day corrective action plan, I need to summarize the key points discussed. The plan involves EHR changes with a discharge hard-stop for 'Reconcile and Sign', requiring 120 hours of build effort and 2 weeks of testing, as well as a 15-minute microlearning module for approximately 850 learners. Pharmacy Informatics Lead has indicated that the EHR change is expected to streamline the medication reconciliation process. Quality & Patient Safety Director, can you confirm if there are any indicators of patient harm trajectory or operational strain that we should be aware of? Additionally, I will share that the estimated one-time cost for remediation is $410,000, with $240,000 attributed to staffing backfill.

--- Round 4 ---
[R4.1] Quality & Patient Safety Director (speak, public): To finalize our discussion on the proposed 60-day corrective action plan, let's summarize the key points: the EHR changes include a discharge hard-stop for 'Reconcile and Sign', requiring 120 hours of build effort and 2 weeks of testing; the training involves a 15-minute microlearning module for approximately 850 learners; and the estimated one-time cost for remediation is $410,000, with $240,000 attributed to staffing backfill. Given these details, I believe the plan is feasible and aligns with our goal to improve medication reconciliation reliability. Hospital Finance & Operations Director, can you confirm if the budget allocation is acceptable, and we can move forward with the plan?
[R4.2] Pharmacy Informatics Lead (speak, public): To confirm the feasibility of the proposed 60-day corrective action plan, I believe the EHR changes and training approach outlined are crucial steps toward improving medication reconciliation reliability. Given the estimated one-time cost for remediation is $410,000, with $240,000 attributed to staffing backfill, I'd like to reiterate that the proposed changes are expected to streamline the medication reconciliation process, potentially reducing the current average verification time of 18 minutes per patient. I recommend proceeding with the plan while closely monitoring the implementation phase for any operational strain.
[R4.3] Hospital Finance & Operations Director (speak, public): To finalize our discussion on the proposed 60-day corrective action plan, I have assessed the financial and operational viability based on the information shared. The estimated one-time cost for remediation is $410,000, with $240,000 attributed to staffing backfill. Given the potential to improve medication reconciliation reliability and reduce preventable Adverse Drug Events (ADEs), I recommend approving the plan. However, we need to closely monitor the implementation phase for any operational strain and ensure that the budget allocation is managed effectively. I propose that we proceed with the plan while maintaining regular check-ins to address any challenges that arise during the 60-day period.

--- Round 5 ---
[R5.1] Quality & Patient Safety Director (speak, public): I recommend that we approve the proposed 60-day corrective action plan to improve inpatient medication reconciliation reliability. The plan includes EHR changes and a microlearning training module, with an estimated one-time cost of $410,000. Given the potential to reduce preventable Adverse Drug Events and improve patient safety, I believe the benefits outweigh the costs. Let's proceed with the plan while maintaining regular check-ins to address any operational challenges.
[R5.2] Pharmacy Informatics Lead (leave, public): 
[R5.3] Hospital Finance & Operations Director (leave, public): 

--- Round 6 ---
[R6.1] Quality & Patient Safety Director (leave, public): 
[R6.2] Pharmacy Informatics Lead (leave, public): 
[R6.3] Hospital Finance & Operations Director (leave, public): 

--- Round 7 ---
[R7.1] Quality & Patient Safety Director (leave, public): 
[R7.2] Pharmacy Informatics Lead (leave, public): 
[R7.3] Hospital Finance & Operations Director (leave, public): 

--- Round 8 ---
[R8.1] Quality & Patient Safety Director (leave, public): 
[R8.2] Pharmacy Informatics Lead (leave, public): 
[R8.3] Hospital Finance & Operations Director (leave, public): 

--- Round 9 ---
[R9.1] Quality & Patient Safety Director (leave, public): 
[R9.2] Pharmacy Informatics Lead (leave, public): 
[R9.3] Hospital Finance & Operations Director (leave, public): 

--- Round 10 ---
[R10.1] Quality & Patient Safety Director (leave, public): 
[R10.2] Pharmacy Informatics Lead (leave, public): 
[R10.3] Hospital Finance & Operations Director (leave, public): 

--- Round 11 ---
[R11.1] Quality & Patient Safety Director (leave, public): 
[R11.2] Pharmacy Informatics Lead (leave, public): 
[R11.3] Hospital Finance & Operations Director (leave, public): 

--- Round 12 ---
[R12.1] Quality & Patient Safety Director (leave, public): 
[R12.2] Pharmacy Informatics Lead (leave, public): 
[R12.3] Hospital Finance & Operations Director (leave, public): 

--- Round 13 ---
[R13.1] Quality & Patient Safety Director (leave, public): 
[R13.2] Pharmacy Informatics Lead (leave, public): 
[R13.3] Hospital Finance & Operations Director (leave, public): 

--- Round 14 ---
[R14.1] Quality & Patient Safety Director (leave, public): 
[R14.2] Pharmacy Informatics Lead (leave, public): 
[R14.3] Hospital Finance & Operations Director (leave, public): 

--- Round 15 ---
[R15.1] Quality & Patient Safety Director (leave, public): 
[R15.2] Pharmacy Informatics Lead (leave, public): 
[R15.3] Hospital Finance & Operations Director (leave, public): 

--- Round 16 ---
[R16.1] Quality & Patient Safety Director (leave, public): 
[R16.2] Pharmacy Informatics Lead (leave, public): 
[R16.3] Hospital Finance & Operations Director (leave, public): 

--- Round 17 ---
[R17.1] Quality & Patient Safety Director (leave, public): 
[R17.2] Pharmacy Informatics Lead (leave, public): 
[R17.3] Hospital Finance & Operations Director (leave, public): 

--- Round 18 ---
[R18.1] Quality & Patient Safety Director (leave, public): 
[R18.2] Pharmacy Informatics Lead (leave, public): 
[R18.3] Hospital Finance & Operations Director (leave, public): 

--- Round 19 ---
[R19.1] Quality & Patient Safety Director (leave, public): 
[R19.2] Pharmacy Informatics Lead (leave, public): 
[R19.3] Hospital Finance & Operations Director (leave, public): 

